237 related articles for article (PubMed ID: 18393326)
1. Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
Weight CJ; Klein EA; Jones JS
Cancer; 2008 May; 112(10):2195-201. PubMed ID: 18393326
[TBL] [Abstract][Full Text] [Related]
2. Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis.
Chang SL; Liao JC; Shinghal R
J Urol; 2009 Jul; 182(1):255-60; discussion 261. PubMed ID: 19450844
[TBL] [Abstract][Full Text] [Related]
3. Reimbursement policy and androgen-deprivation therapy for prostate cancer.
Shahinian VB; Kuo YF; Gilbert SM
N Engl J Med; 2010 Nov; 363(19):1822-32. PubMed ID: 21047226
[TBL] [Abstract][Full Text] [Related]
4. The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer.
Chon JK; Jacobs SC; Naslund MJ
J Urol; 2000 Sep; 164(3 Pt 1):735-7. PubMed ID: 10953136
[TBL] [Abstract][Full Text] [Related]
5. Does reimbursement influence chemotherapy treatment for cancer patients?
Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993.
Litwin MS; Pasta DJ; Stoddard ML; Henning JM; Carroll PR
J Urol; 1998 Aug; 160(2):445-8. PubMed ID: 9679895
[TBL] [Abstract][Full Text] [Related]
7. Medical versus surgical androgen suppression therapy for prostate cancer: a 10-year longitudinal cost study.
Mariani AJ; Glover M; Arita S
J Urol; 2001 Jan; 165(1):104-7. PubMed ID: 11125375
[TBL] [Abstract][Full Text] [Related]
8. [Surgical or medical castration with LH-RH analogue for prostatic cancer].
Kameyama S; Yamazaki S; Kitamura T
Nihon Rinsho; 1998 Aug; 56(8):2114-8. PubMed ID: 9750518
[TBL] [Abstract][Full Text] [Related]
9. Is the increase in orchiectomy for prostate cancer patients appropriate?
Chodak GW
Cancer; 2008 May; 112(10):2106-7. PubMed ID: 18386828
[No Abstract] [Full Text] [Related]
10. Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer.
Garje R; Chennamadhavuni A; Mott SL; Chambers IM; Gellhaus P; Zakharia Y; Brown JA
Clin Genitourin Cancer; 2020 Apr; 18(2):e157-e166. PubMed ID: 31956009
[TBL] [Abstract][Full Text] [Related]
11. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
[TBL] [Abstract][Full Text] [Related]
12. Medicare in interventional pain management: A critical analysis.
Manchikanti L
Pain Physician; 2006 Jul; 9(3):171-97. PubMed ID: 16886027
[TBL] [Abstract][Full Text] [Related]
13. Medicare reimbursement and prescribing hormone therapy for prostate cancer.
Keating NL
J Natl Cancer Inst; 2010 Dec; 102(24):1814-5. PubMed ID: 21131579
[No Abstract] [Full Text] [Related]
14. The fate of the medically castrated testis: expectation versus reality.
Issa MM; Krishnan A; Bouet R; Young MR; Hood N; Petros JA
J Urol; 2004 Sep; 172(3):1042-4. PubMed ID: 15311033
[TBL] [Abstract][Full Text] [Related]
15. Impact of the National Health Fund policy on hormone treatment for prostate cancer in Jamaica.
Morrison BF; Aiken WD; Reid ME
Rev Panam Salud Publica; 2011 Jun; 29(6):404-8. PubMed ID: 21829963
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States.
Cetin K; Li S; Blaes AH; Stryker S; Liede A; Arneson TJ
Urology; 2013 Jun; 81(6):1184-9. PubMed ID: 23601449
[TBL] [Abstract][Full Text] [Related]
17. Timing of androgen deprivation therapy: some questions answered, others not.
Schellhammer PF
J Natl Cancer Inst; 2006 Jun; 98(12):802-3. PubMed ID: 16788149
[No Abstract] [Full Text] [Related]
18. Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment.
Ellis SD; Chen RC; Dusetzina SB; Wheeler SB; Jackson GL; Nielsen ME; Carpenter WR; Weinberger M
J Oncol Pract; 2016 Apr; 12(4):e423-36. PubMed ID: 26957641
[TBL] [Abstract][Full Text] [Related]
19. Impact of surgical and medical castration on serum testosterone level in prostate cancer patients.
Novara G; Galfano A; Secco S; Ficarra V; Artibani W
Urol Int; 2009; 82(3):249-55. PubMed ID: 19440008
[TBL] [Abstract][Full Text] [Related]
20. The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?
Friedman JY; Curtis LH; Hammill BG; Dhillon JK; Weaver CH; Biswas S; Abernethy AP; Schulman KA
Cancer; 2007 Nov; 110(10):2304-12. PubMed ID: 17924373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
